Preventive health, GLP-1s, behavior change, AI coaching, longevity, diagnostics, and consumerization—Geoff Cook and SCALE explore how Noom is evolving from a weight-loss app into a broader everyday health platform.

In this episode of Analyzing Healthcare by SCALE Community, Noom CEO Geoff Cook explains how the company is adapting to the GLP-1 era while remaining focused on sustainable habits and behavior change. He discusses why medication is only one part of the solution and how Noom is integrating clinical care, diagnostics, coaching, gamification, and AI.

The conversation also examines the shift from episodic care to always-on health platforms, Noom’s engagement advantage with employers and health plans, and the role interoperability could play in connecting consumer data with the wider healthcare system.

What You’ll Learn

✅ Why Noom defines itself as a preventive health and longevity platform
✅ How GLP-1s changed Noom’s strategy
✅ Why medication must be paired with behavior change
✅ How Noom drives consumer engagement through habits, coaching, and gamification
✅ Why preventive care may be moving beyond traditional primary care
✅ How diagnostics, wearables, AI, and clinical access are converging
✅ Why interoperability could reshape consumer health
✅ What could drive long-term GLP-1 adoption

Key Timestamps

• (01:34) What Noom is today
• (02:40) Building a GLP-1 companion
• (03:51) Medication plus behavior change
• (04:45) Consumer business vs. enterprise growth
• (06:22) GLP-1 as a tool, not the full solution
• (08:35) GLP-1 engagement and retention
• (09:31) Gamification, seeds, and habit incentives
• (10:29) Health outcomes beyond weight loss
• (14:04) Preventive care vs. primary care
• (17:29) Diagnostics, convenient care, and lifestyle support
• (19:09) AI in coaching and biomarker screening
• (21:31) Can preventive care bend the cost curve?
• (24:20) Bringing longevity medicine mainstream
• (28:24) Regulation and interoperability
• (33:17) Why people stop GLP-1s

Key Takeaways

• 💎 Noom is positioning itself as a preventive health and longevity platform, not just a weight loss app.
• 💎 GLP-1s can accelerate early success, but sustainable outcomes still depend on habits.
• 💎 Consumer trust and brand recognition help Noom drive stronger employer and health plan engagement.
• 💎 Preventive care is becoming more proactive, consumer-led, and data-driven.
• 💎 AI can help personalize coaching, interpret biomarkers, and guide next actions.
• 💎 Interoperability may allow consumer health data to become part of the broader medical record.
• 💎 Price and side effects remain major barriers to long-term GLP-1 use.

Guest Bio

Geoff Cook is CEO of Noom, where he drove the launch of Noom Med product lines, growing it from zero to two-thirds of Noom’s total revenue within 3 years of joining; introduced AI tools including Face Scan and Future Me; and led the convergence of diagnostics, behavior, and care. He also established Noom’s mission to help everyone live better longer. Previously, Geoff co-founded The Meet Group, serving as CEO through its $500 million sale in 2020.

Resource Links

Guest: Geoff Cook – CEO, Noom
Podcast: Analyzing Healthcare by SCALE Community
SCALE Community: https://www.scale-community.com

SEO Keywords

Noom, Geoff Cook, GLP-1, Preventive Health, Longevity, Behavior Change, AI in Healthcare, Healthcare Consumerization, Weight Loss, Health Coaching, Digital Health, Diagnostics, Interoperability, Value-Based Care, Employer Health, Payor Strategy, Healthcare Podcast, Healthcare Trends and Innovations, Healthcare Strategies, Leading Healthcare Stakeholders, Thought Leaders in Healthcare, Healthcare Industry Insights, Healthcare Innovations, Healthcare Strategy, Latest Trends in Healthcare, Healthcare Thought Leadership, Scale Healthcare, Roy Bejarano, Scale Community, Jason Schifman